| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.45B | 69.50B | 58.97B | 68.46B | 55.76B | 42.21B |
| Gross Profit | 27.89B | 25.97B | 20.57B | 28.41B | 23.08B | 16.35B |
| EBITDA | 26.60B | 24.71B | 19.29B | 24.42B | 19.49B | 14.66B |
| Net Income | 12.89B | 11.62B | 8.34B | 14.13B | 10.89B | 6.81B |
Balance Sheet | ||||||
| Total Assets | 144.45B | 141.50B | 133.74B | 113.53B | 92.01B | 76.03B |
| Cash, Cash Equivalents and Short-Term Investments | 33.46B | 31.30B | 31.47B | 23.41B | 24.36B | 25.71B |
| Total Debt | 18.90B | 20.00B | 20.00B | 24.82M | 19.77M | 21.87M |
| Total Liabilities | 34.66B | 37.45B | 38.72B | 26.03B | 16.71B | 9.86B |
| Stockholders Equity | 109.79B | 104.05B | 95.03B | 87.50B | 75.30B | 66.17B |
Cash Flow | ||||||
| Free Cash Flow | 7.21B | 4.38B | -10.52B | 291.18M | 577.39M | 10.61B |
| Operating Cash Flow | 19.73B | 22.73B | 7.06B | 13.93B | 10.20B | 12.82B |
| Investing Cash Flow | -14.59B | -20.57B | -18.58B | -13.42B | -9.38B | -2.62B |
| Financing Cash Flow | -3.69B | -2.41B | 17.66B | -2.12B | -2.88B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥224.15B | 17.39 | ― | 1.24% | 8.80% | 33.39% | |
74 Outperform | ¥200.18B | 12.74 | ― | 4.20% | 1.69% | 0.94% | |
74 Outperform | ¥181.30B | 19.02 | 4.41% | 3.86% | -1.50% | -32.46% | |
73 Outperform | ¥266.66B | 11.54 | 8.79% | 4.02% | 6.60% | 503.36% | |
64 Neutral | ¥228.93B | -19.45 | -4.00% | 3.80% | 0.24% | -234.36% | |
64 Neutral | ¥92.67B | 10.03 | ― | 3.92% | 2.61% | 30.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Fuso Chemical Co., Ltd. has announced an increase in its interim and year-end dividend forecasts for the fiscal year ending March 2026. The decision, made during a Board of Directors meeting, reflects the company’s revised earnings forecasts and commitment to progressive dividends, resulting in an annual dividend forecast of ¥82 per share, up from the previous forecast of ¥76.
Fuso Chemical Co., Ltd. has revised its earnings and dividend forecasts for the fiscal year ending March 2026, citing strong sales of colloidal silica in the semiconductor market and favorable foreign exchange conditions. The company has reported higher-than-expected profits and sales, driven by increased demand in the semiconductor industry and advantageous currency fluctuations, leading to an upward revision of its full-year earnings forecasts.
Fuso Chemical Co., Ltd. reported a notable increase in its consolidated financial results for the six months ended September 30, 2025, with net sales rising by 8.5% and operating profit by 19.7% compared to the previous year. The company also announced a revision in its cash dividend forecast, indicating a positive outlook for stakeholders.
Fuso Chemical Co., Ltd. announced several personnel changes effective October 1, 2025, aimed at strengthening its production and business planning divisions. These changes include new department manager appointments in key areas such as electronic materials quality assurance and production engineering management, which are expected to enhance the company’s operational efficiency and strategic positioning in the chemical industry.